Berfelde, J.; Hildebrand, L.S.; Kuhlmann, L.; Fietkau, R.; Distel, L.V.
FEN1 Inhibition as a Potential Novel Targeted Therapy against Breast Cancer and the Prognostic Relevance of FEN1. Int. J. Mol. Sci. 2024, 25, 2110.
https://doi.org/10.3390/ijms25042110
AMA Style
Berfelde J, Hildebrand LS, Kuhlmann L, Fietkau R, Distel LV.
FEN1 Inhibition as a Potential Novel Targeted Therapy against Breast Cancer and the Prognostic Relevance of FEN1. International Journal of Molecular Sciences. 2024; 25(4):2110.
https://doi.org/10.3390/ijms25042110
Chicago/Turabian Style
Berfelde, Johanna, Laura S. Hildebrand, Lukas Kuhlmann, Rainer Fietkau, and Luitpold V. Distel.
2024. "FEN1 Inhibition as a Potential Novel Targeted Therapy against Breast Cancer and the Prognostic Relevance of FEN1" International Journal of Molecular Sciences 25, no. 4: 2110.
https://doi.org/10.3390/ijms25042110
APA Style
Berfelde, J., Hildebrand, L. S., Kuhlmann, L., Fietkau, R., & Distel, L. V.
(2024). FEN1 Inhibition as a Potential Novel Targeted Therapy against Breast Cancer and the Prognostic Relevance of FEN1. International Journal of Molecular Sciences, 25(4), 2110.
https://doi.org/10.3390/ijms25042110